GSK Pharma names Sukanya Choudhury as Regulatory Head, Growth Emerging Markets

Published On 2025-05-03 06:30 GMT   |   Update On 2025-05-03 06:30 GMT
Advertisement

GlaxoSmithKline Pharmaceuticals Limited has announced that Sukanya Choudhury, Executive Vice President - Regulatory Affairs has taken a secondment role as Regulatory Head, Growth Emerging Markets for period of 16 months with effect from 1st May 2025.

Pursuant to her secondment, she will also cease to be the Senior Management Personnel of the Company effective the same date.

Read also: GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices

Advertisement

Choudhury has had a distinguished career with GSK, which she joined in 2007 as Senior Manager – Regulatory Affairs. Over the years, she rose through the ranks, becoming General Manager – Regulatory Affairs in 2013, and later promoted to Vice President – Regulatory Affairs in 2016.

She began her professional journey with East India Pharmaceutical Works Ltd in 1998, and went on to hold roles at Alembic Pharmaceuticals, Eli Lilly, and Boston Scientific.

Read also: GSK Arexvy recommended for adults aged 50-59 at increased risk for severe RSV disease by US Advisory Committee on Immunization Practices



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News